-+ 0.00%
-+ 0.00%
-+ 0.00%

REZOLUTE INC: PHASE 3 UPLIFT STUDY FOR TUMOR HI IS ONGOING WITH TOPLINE RESULTS EXPECTED IN SECOND HALF OF 2026

Reuters·12/11/2025 12:00:40

Please log in to view news